Christian D. Lates

Education

• BA, Biological Sciences, Canisius College, Buffalo, NY, 1990
• MD, State University of NY at Buffalo School of Medicine, Buffalo, NY, 1994
• Pathology Training, State University of New York at Buffalo, Buffalo, NY, 1995
• Residency, State University of New York at Buffalo, Medicine Program (Millard Fillmore Hospital), 1998

Certifications/Memberships

• Board Certification in Internal Medicine
• American College of Physicians

Research

1991 - Research grant through State University of New York at Buffalo, Buffalo, NY (headed by Dr. Flanagan) Mineralocorticoid induced hypertension in the animal model (Mentor: Dr. Samuel Gallant)

1987-1988 - Dana Farber Research Grant award recipient. Research in Mineralocorticoid induced hypertension at State University of New York at Buffalo Department of Pathology (Mentor: Dr. Samuel Gallant)

Publications

Magee MH, Blum RA, Lates CD, Jusko WJ. Predinsolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race. Journal of Clinical Pharmacology 2001; 41: 1180-1194

Blum RA, Majumdar A, McCrea J, Busillo J, Orlowski LH, Panebianco D, Hesney M, Petty KJ, Goldberg MR, Murphy MG, Gottesdiener KM, Hustad CM, Lates CD, Kraft WK, Buren SV, Waldeman SA, Greenberg HE. Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects. Clin Ther 2003; 25: 1407-1419

Mager DE, Lin SX, Blum RA, Lates CD, Jusko WJ. Dose Equivalency Evaluation of Major Corticosteriods: Pharmacokinetics and Cell Trafficking and Cortisol Dynamics. Journal of Clinical Pharmacology, 2003; Vol 43, 11, pp. 1216-1227

Johnson B, Adams I, Lebowitz P, Lates, CD, Blum RA, Zhang E. Impact of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of ondansetron and dexamethasone. Support Care Cance (2009) 17: 1177-1185

Johnson B, Adams L, Lu E, Zhang K, Lebowitz P, Lates CD, Blum R., Impact of casopitatn, a novel NK-1 antagonist, on the pharmacokinetics of ondansetron and dexamethasone. Support Care Cancer 2009; 17(9): 1177-1185

Kirby LC, Johnson BM, Adams LM, Eberwein DJ, Zhang K, Murray SC, Lates CD, Blum RA, Morris SR. Effect of casopitant, a novel NK-1 receptor antagonist, on the pharmacokinetics and pharmacodynamics of steady-sate warfarin. Journal of Clinical Pharmacology 2010; 50: 566-575